Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Presolicitation

PAXgene Blood RNA Extraction, Quantitation, Normalization, Agilent Quality Control, and Aliquoting Services

75N98026Q00701

National Institutes of Health, National Institutes of Health Olao. Research and Development in Biotechnology (except Nanobiotechnology).

Response deadline

July 6, 2026 at 9:00 AM EDT

Closed 118 days ago. Posted June 24, 2026. Scheduled to archive July 21, 2026.

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one closed in 2026

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

General Information

Document Type:

Presolicitation

Synopsis Number:

75N98026Q00701

Posted Date:

June 24, 2026

Original Response Date:

July 6, 2026

Current Response Date:

July 6, 2026

Set Aside:

N/A

NAICS Code:

541714

Contracting Office Address

National Institutes of Health (NIH), Office of the Director (OD)

Office of Logistics and Operations (OLAO)

Office of Acquisition and Logistics Management (OALM)

Hospital and Laboratory Support Division

6701 Rockledge Drive

Bethesda, MD 20817 

Description

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:

9000 Virginia Manor Rd

Suite 207

Beltsville MD 20705

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 541714 with a Size Standard $.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

GENERAL INFORMATION

  1. Title: PAXgene Blood RNA Extraction, Quantitation, Normalization, Agilent Quality Control, and Aliquoting Services
  2. Background Information: The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), requires laboratory services to process whole-blood RNA specimens collected under an ongoing clinical research study (POTS) in the laboratory of Dr. Paule Joseph at the NIH (Building 10, Bethesda, Maryland). To date, 124 PAXgene Blood RNA tubes have been collected from 31 enrolled human research participants (approximately four tubes per participant). These time-sensitive, irreplaceable specimens must be professionally processed to yield analysis-ready total RNA. The requiring laboratory does not have the in-house validated workflow or capacity to extract, quality-control, and aliquot the samples to the required standard within the necessary timeframe. The acquisition is therefore pursued to obtain these specialized services from a qualified provider so that the study's gene-expression analyses can proceed without loss of specimen integrity or previously collected clinical data.

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by July 6, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00701. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.

"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 24, 2026

    Presolicitation

    Due July 6, 2026 at 9:00 AM EDT. SAM.gov, notice 80326c62141d48d1bd085b45eb72f3e2

    1 revisions on SAM
    • June 24, 2026: publish, presolicitation

Points of contact